Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Staal-Schreinemachers, A. L.
Right arrow Articles by Lakke, J. P.W.F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Staal-Schreinemachers, A. L.
Right arrow Articles by Lakke, J. P.W.F.
NEUROLOGY 1986;36:291
© 1986 American Academy of Neurology

Low-dose bromocriptine therapy in Parkinson's disease

Double-blind, placebo-controlled study

A. L. Staal-Schreinemachers, H. Wesseling, D. J. Kamphuis, W.v.d. Burg and J. P.W.F. Lakke

Department of Neurology, University Hospital, Groningen, The Netherlands.

Twenty-one de novo parkinsonian patients in stage I to III of the Hoehn and Yahr scale completed a 6-month, double-blind, placebo-controlled study. Low-dose bromocriptine (15 mg daily) was effective. Rigidity improved more than tremor or bradykinesia. Sustained satisfactory benefit was seen only in patients with mild Parkinson's disease.

Address correspondence and reprint requests to Dr. Staal-Schreinemachers, University Hospital, Department of Neurology, Oostersingel 59, 9713 EZ Groningen, The Netherlands.

Accepted for publication June 19, 1985.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by AAN Enterprises, Inc.